Int J Cancer 2009,125(7):1505–1513.PubMedCrossRef 5. Mori Y, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Kurehara H, Mori R, Tomoda K, Ogawa R, Talazoparib research buy Katada T, Harata K, Fujii Y: Expression of ECRG4 is an independent prognostic factor for poor survival
in patients with esophageal squamous cell carcinoma. Oncol Rep 2007,18(4):981–985.PubMed 6. Demokan S, Chang X, Chuang A, Mydlarz WK, Kaur J, Huang P, Khan Z, Khan T, Ostrow KL, Brait M, Hoque MO, Liegeois NJ, Sidransky D, Koch W, Califano JA: KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer 2010, in press. 7. Lee J, Jeong DJ, Kim J, Lee S, Park JH, Chang B, Jung SI, Yi L, Han Y, Yang Y, Kim KI, Lim JS, Yang I, Jeon S, Bae DH, Kim CJ, Lee MS: The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma. Mol Cancer 2010, 9:109.PubMedCrossRef 8. Yang Z, Wang Y, Fang J, Chen F, Liu J, Wu J, Wang Y: Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas. J Exp Clin Cancer Res 2010, 29:26.PubMedCrossRef 9. Torng PL, Lin CW, Chan MW, Yang HW, Huang SC, Lin CT: Promoter methylation
of IGFBP-3 and Lonafarnib datasheet p53 expression in ovarian endometrioid carcinoma. Mol Cancer 2009, 8:-120. 10. Wu CS, Lu YJ, Li HP, Hsueh C, Lu CY, Leu YW, Liu HP, Lin KH, Hui-Ming Huang T, Chang YS: Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer 2010,126(11):2542–2552.PubMed 11. Vanaja DK, Ehrich M, Van den BD: Hypermethylation of Genes for Diagnosis and Risk Stratification of Prostate Cancer. Cancer Invest 2009,27(5):549–560.PubMedCrossRef 12. Götze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, Tannapfel A, Kuhnen C, Martin D, VAV2 Müller O, Sievers S: ECRG4 is a candidate tumor suppressor gene frequently buy FHPI hypermethylated in colorectal carcinoma and glioma. BMC Cancer 2009, 9:447.PubMedCrossRef 13. Tu L, Liu Z, He X, He Y, Yang H, Jiang Q, Xie S, Xiao G, Li X, Yao K, Fang W: Over-expression
of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Mol Cancer 2010, 9:78.PubMedCrossRef 14. Steck E, Breit S, Breusch SJ, Axt M, Richter W: Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage. Biochem Biophys Res Commun 2002,299(1):109–115.PubMedCrossRef 15. Gilmore TD, Koedood M, Piffat KA, White DW: Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene 1996,13(7):1367–1378.PubMed 16. Lee CH, Jeon YT, Kim SH, Song YS: NF-κB as a potential molecular target for cancer therapy. Biofactors 2007,29(1):19–35. ReviewPubMedCrossRef 17.